Locally advanced squamous cervical carcinoma (M0): management and emerging therapeutic options in the precision radiotherapy era

Jpn J Radiol. 2024 Apr;42(4):354-366. doi: 10.1007/s11604-023-01510-2. Epub 2023 Nov 21.

Abstract

Squamous cervical carcinoma (SCC) requires particular attention in diagnostic and clinical management. New diagnostic tools, such as (positron emission tomography-magnetic resonance imaging) PET-MRI, consent to ameliorate clinical staging accuracy. The availability of new technologies in radiation therapy permits to deliver higher dose lowering toxicities. In this clinical scenario, new surgical concepts could aid in general management. Lastly, new targeted therapies and immunotherapy will have more room in this setting. The aim of this narrative review is to focus both on clinical management and new therapies in the precision radiotherapy era.

Keywords: Brachytherapy; Cervical carcinoma; Chemoradiotherapy; HPV; Immunotherapy; Locally advanced squamous cervical carcinoma; PET; Target therapy.

Publication types

  • Review

MeSH terms

  • Carcinoma, Squamous Cell* / diagnostic imaging
  • Carcinoma, Squamous Cell* / radiotherapy
  • Chemoradiotherapy / methods
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Magnetic Resonance Spectroscopy
  • Neoplasm Staging
  • Positron-Emission Tomography
  • Uterine Cervical Neoplasms* / diagnostic imaging
  • Uterine Cervical Neoplasms* / radiotherapy